Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8494021rdf:typepubmed:Citationlld:pubmed
pubmed-article:8494021lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:8494021lifeskim:mentionsumls-concept:C0014792lld:lifeskim
pubmed-article:8494021lifeskim:mentionsumls-concept:C0017661lld:lifeskim
pubmed-article:8494021lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:8494021pubmed:issue5 Suppl 2lld:pubmed
pubmed-article:8494021pubmed:dateCreated1993-6-11lld:pubmed
pubmed-article:8494021pubmed:abstractTextIn this paper we report some results of our studies on patients with immunoglobulin (Ig)A nephropathy regarding (1) the familiar aggregation of erythrocyte sodium-lithium (Na,Li) countertransport; (2) the association of Na,Li countertransport with the presence of arterial hypertension and lipid abnormalities; (3) the correlation between Na,Li countertransport activity and renal functional reserve; and (4) the preliminary results of a longitudinal study. In 13 families of patients with IgA nephropathy, selected because both parents were available, we found a significant correlation between midparent and offspring Na,Li countertransport activity (Spearman's rank correlation = 0.65; P = 0.023), but no husband-wife relationship. In 49 patients, the activity of Na,Li countertransport was significantly higher in erythrocytes from 20 hypertensive patients than from either 29 normotensive patients or from 36 healthy age- and sex-matched normal subjects. Hyperlipidemic patients had an erythrocyte Na,Li countertransport activity significantly higher than normolipidemic patients and controls. In 17 patients a significant inverse correlation was found between the peak variation of creatinine clearance over baseline value after an oral protein load and the erythrocyte Na,Li countertransport activity (Spearman r = 0.54; P = 0.03). In a longitudinal study of 36 patients followed from 12 to 36 months, those showing a progression toward renal failure had an erythrocyte Na,Li countertransport activity higher than median value. The results of our studies show that in patients with IgA nephropathy a high erythrocyte Na,Li countertransport rate, genetically determined, is associated with the presence of arterial hypertension and lipid abnormalities, and perhaps with a less favorable disease outcome.lld:pubmed
pubmed-article:8494021pubmed:languageenglld:pubmed
pubmed-article:8494021pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8494021pubmed:citationSubsetIMlld:pubmed
pubmed-article:8494021pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8494021pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8494021pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8494021pubmed:statusMEDLINElld:pubmed
pubmed-article:8494021pubmed:monthMaylld:pubmed
pubmed-article:8494021pubmed:issn0272-6386lld:pubmed
pubmed-article:8494021pubmed:authorpubmed-author:FabbriAAlld:pubmed
pubmed-article:8494021pubmed:authorpubmed-author:FusaroliMMlld:pubmed
pubmed-article:8494021pubmed:authorpubmed-author:PiccoliGGlld:pubmed
pubmed-article:8494021pubmed:authorpubmed-author:QuarelloFFlld:pubmed
pubmed-article:8494021pubmed:authorpubmed-author:SturaniAAlld:pubmed
pubmed-article:8494021pubmed:authorpubmed-author:Degli...lld:pubmed
pubmed-article:8494021pubmed:authorpubmed-author:BoeroRRlld:pubmed
pubmed-article:8494021pubmed:authorpubmed-author:GuarenaCClld:pubmed
pubmed-article:8494021pubmed:authorpubmed-author:FornerisGGlld:pubmed
pubmed-article:8494021pubmed:authorpubmed-author:LucatelloAAlld:pubmed
pubmed-article:8494021pubmed:issnTypePrintlld:pubmed
pubmed-article:8494021pubmed:volume21lld:pubmed
pubmed-article:8494021pubmed:ownerNLMlld:pubmed
pubmed-article:8494021pubmed:authorsCompleteYlld:pubmed
pubmed-article:8494021pubmed:pagination61-5lld:pubmed
pubmed-article:8494021pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8494021pubmed:meshHeadingpubmed-meshheading:8494021-...lld:pubmed
pubmed-article:8494021pubmed:meshHeadingpubmed-meshheading:8494021-...lld:pubmed
pubmed-article:8494021pubmed:meshHeadingpubmed-meshheading:8494021-...lld:pubmed
pubmed-article:8494021pubmed:meshHeadingpubmed-meshheading:8494021-...lld:pubmed
pubmed-article:8494021pubmed:meshHeadingpubmed-meshheading:8494021-...lld:pubmed
pubmed-article:8494021pubmed:meshHeadingpubmed-meshheading:8494021-...lld:pubmed
pubmed-article:8494021pubmed:meshHeadingpubmed-meshheading:8494021-...lld:pubmed
pubmed-article:8494021pubmed:meshHeadingpubmed-meshheading:8494021-...lld:pubmed
pubmed-article:8494021pubmed:meshHeadingpubmed-meshheading:8494021-...lld:pubmed
pubmed-article:8494021pubmed:meshHeadingpubmed-meshheading:8494021-...lld:pubmed
pubmed-article:8494021pubmed:meshHeadingpubmed-meshheading:8494021-...lld:pubmed
pubmed-article:8494021pubmed:meshHeadingpubmed-meshheading:8494021-...lld:pubmed
pubmed-article:8494021pubmed:meshHeadingpubmed-meshheading:8494021-...lld:pubmed
pubmed-article:8494021pubmed:meshHeadingpubmed-meshheading:8494021-...lld:pubmed
pubmed-article:8494021pubmed:year1993lld:pubmed
pubmed-article:8494021pubmed:articleTitleSodium-lithium countertransport activity in red blood cells of patients with IgA nephropathy.lld:pubmed
pubmed-article:8494021pubmed:affiliationIstituto di Nefro-Urologia dell'Università, Ospedale G. Bosco, Torino, Italy.lld:pubmed
pubmed-article:8494021pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8494021pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8494021lld:pubmed